Phoreus Biotechnology, Inc. is the provider of a proprietary technology platform with the capacity to revolutionize global One Health. Our Branched Amphipathic Peptide Capsules™ (BAPC™) offer substantially increased efficacy in the creation and delivery of novel vaccines, cancer therapies, alternative antibiotics and biopesticides for improved human, animal, plant and environmental health around the world.
Learn how our technology works below.
Branched Amphipathic Peptide Capsules (BAPC) are self-assembling nanocarriers functioning as delivery vehicles that overcome many of the poor absorption issues that plague certain classes of drugs. Both hydrophobic and hydrophilic small molecules, proteins and nucleic acids can be either bound to or encapsulated within the compartments of the BAPC nanomaterials.
More robust than lipid vesicles, BAPC are programmable in size ranging from 6-2000 nanometers. Their supramolecular self-assembly forms solvent-filled bilayer delineated capsules capable of encapsulating fluorescent dyes, therapeutic drugs, radionuclides and small proteins as well as binding with oligonucleotides or plasmids.
BAPC have application in development and delivery of novel vaccines, alternative antibiotics, cancer therapies and agricultural biopesticides.
Our products are priced more competitively than current products
We make it simple to move from in-vitro research to in-vivo application
We help your products work better, providing superior results
We are devoted to improving human, environmental, and animal health
